Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €31.68 EUR
Change Today -0.61 / -1.88%
Volume 497.4K
SAZ On Other Exchanges
Symbol
Exchange
Xetra
OTC US
Xetra
As of 3:35 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Hartmut Retzlaff

Chairman of The Executive Board, Stada-Arzneimittel AG
AgeTotal Calculated CompensationThis person is connected to 65 board members in 2 different organizations across 5 different industries.

See Board Relationships
61€2,848,000
As of Fiscal Year 2014

Background*

Mr. Hartmut Ulrich Retzlaff serves as the Chief Executive Officer of Stada-Arzneimittel AG and has been its Chairman of Executive Board since 1993. Mr. Retzlaff serves as a Member of the Executive Board at Stada Arzneimittel AG since 1992. He serves as a Member of Exchange Council at Frankfurt Stock Exchange. He served as Chief Executive Officer, Chairman and Member of the Executive Board of Stada Pharmaceuticals, Inc. From 1986 to 1990, he served as Director of Marketing ...

Read Full Background

Corporate Headquarters*

Stadastrasse 2-18
Bad Vilbel, -- 61118

Germany

Phone: 49 6101 6030
Fax: 49 6101 603 259

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

Salary€2,000,000
Bonus€848,000
Total Annual Compensation€2,848,000

Stock Options*

Long Term Incentive Plan€4,146,000

Total Compensation*

Total Short Term Compensation€2,848,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAZ:GR €31.68 EUR -0.61

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer, President and Director
Endo International plc
$1.1M
Clive A. Meanwell M.D., Ph.D.Chairman and Chief Executive Officer
The Medicines Company
$874.6K
Karl-Ludwig Kley Chairman of Executive Board and Chief Executive Officer
Merck KGaA
€6.6M
Jean-Christophe Tellier Chief Executive Officer and Executive Director
UCB S.A.
--
F. Michael Ball Chief Executive Officer, Director and Member of Science & Technology Committee
Hospira Inc.
$1.1M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STADA ARZNEIMITTEL AG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.